Gastrointestinal Stromal Tumors (GIST) Treatment Support Program for HCP

FOR HEALTHCARE PROFESSIONALS OUTSIDE THE U.S.

SEND TO A COLLEAGUE |

PRINT PAGE | A A A

Home

Helping to Optimize Outcomes in Gastrointestinal Stromal Tumor (GIST)

The Global GIST Explorer app (view demo .wmv or .mov or .flv) is an educational interactive module that simulates the identification and clinical investigation of gastrointestinal stromal tumors (GISTs) in three areas; the oesophagogastric region, the small intestine and the large intestine.
CLICK HERE to download iPad application
CLICK HERE to download MAC application
CLICK HERE to download PC application

GIST Diagnosis

GIST is relatively uncommon, so differential diagnosis can be complicated. KIT staining provides important information that can help confirm a diagnosis.¹

Learn More

Histologic appearances of GIST

Treatment for GIST

The treatment for GIST depends on a number of factors, including the patient's general health and disease status.Learn More

Baseline spiral computed tomography scan

Learn more about tyrosine kinase inhibitors

Risk of GIST Recurrence

Learn about enhanced risk stratification criteria for GIST, including tumor size, mitotic index, and tumor site.²

Learn More

View criteria for
risk stratification

What is GIST ALLIANCE?

Novartis, the global leader in KIT+ GIST therapy, has been working with healthcare professionals and patients worldwide to help improve the treatment of KIT+ GIST. GIST ALLIANCE™ is a unique support program designed to help optimize outcomes in KIT+ GIST patients.

Demetri GD, Benjamin RS, Blanke CD, et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)—update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2007;5(suppl 2):S1-S29.
Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23(2):70-83.

Leading Expert Video Image-Literature Update Series

Disclaimer: This is an international site for Gastrointestinal Stromal Tumors (GIST) and is intended for Health Care Professionals outside the U.S. The information on the site is not country-specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Novartis representative for the latest information specific to your country.